CE-CH-ENV_54_hw2_spring2008

# CE-CH-ENV_54_hw2_spring2008 - CE/CH/ENV-54 Homework 2...

• Notes
• 7

This preview shows pages 1–2. Sign up to view the full content.

CE/CH/ENV-54: Homework 2, Spring 2008 1. A new treatment is developed that prolongs the life of individuals suffering from a particular chronic disease. This disease affects men and women over 65 years of age. Without the new treatment, death within 2 years of diagnosis is typical. With the new treatment, it is estimated that affected individuals will die in 7- 9 years. Considering these facts, answer the following three questions. Be sure to adequately explain your answer. a) How will the new treatment affect the incidence of the disease? Since incidence is calculated in a given time period and this is a chronic disease, the treatment will not necessarily reduce incidence. It does not prevent people from getting the disease (which would decrease the number in the numerator of the incidence equation). Furthermore, a chronic disease indicates that once people have the illness, they will have it for the rest of the calculated time period so the treatment, which just prolongs the amount of time they will live, will not change person time (unless the patient dies). b) How will the new treatment affect the prevalence of the disease? It will slightly increase prevalence. Given that the treatment increases life expectancy, there will be more people aged 65+ alive with the disease at any given time. c) In people 65+, how do you expect the overall mortality rate from this disease will be affected by the new treatment? Again, this is a chronic disease that tends to kill the patients eventually, and the treatment just prolongs their life. The mortality rate might decrease slightly but only because other age-related factors may kill the sick people before the disease does—there is more time for other health problems to arise with the new treatment (so the death would be blamed on something else). Assume all information is the same except that this illness can affect anyone 40 years of age or older. d) In people 50-59, how do you expect the overall mortality rate from this disease will be affected by the new treatment? In people 40-49? In people 60+? As in 1c, the overall mortality rate will probably decrease a little bit. With the extended time patients have to live, there is a higher chance other things could kill them before the disease does, but it is still a chronic disease with a limited life expectancy after diagnosis. 2. Consider the following two incidence graphs of two diseases (note: Males = top line, male and female = middle line, female = bottom line. For the questions, you should just ignore the middle line). For each of the following, state whether you can or cannot answer using just the information contained in the two graphs. If you can answer, do so. If you cannot, state why not. a) Men suffer greater mortality than women from both diseases. Cannot answer. Although the men have a higher rate than women do in both graphs, it could be that the men have either died or gotten better (both would decrease the denominator and we do not know which happened).

This preview has intentionally blurred sections. Sign up to view the full version.

This is the end of the preview. Sign up to access the rest of the document.

{[ snackBarMessage ]}

### What students are saying

• As a current student on this bumpy collegiate pathway, I stumbled upon Course Hero, where I can find study resources for nearly all my courses, get online help from tutors 24/7, and even share my old projects, papers, and lecture notes with other students.

Kiran Temple University Fox School of Business ‘17, Course Hero Intern

• I cannot even describe how much Course Hero helped me this summer. It’s truly become something I can always rely on and help me. In the end, I was not only able to survive summer classes, but I was able to thrive thanks to Course Hero.

Dana University of Pennsylvania ‘17, Course Hero Intern

• The ability to access any university’s resources through Course Hero proved invaluable in my case. I was behind on Tulane coursework and actually used UCLA’s materials to help me move forward and get everything together on time.

Jill Tulane University ‘16, Course Hero Intern